Cleara Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

Cleara Biotech General Information

Description

Operator of a biotechnology company intended to eliminate senescent cells to treat age-related pathologies. The company offers therapeutics that can be used to remove senescence-like cancer cells that are a cause of therapy resistance in terminal cancer, enabling physicians to treat their patients effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cleara Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 02-Feb-2026 Completed Pre-Clinical Trials
4. Later Stage VC 31-Jul-2024 Completed Pre-Clinical Trials
3. Seed Round 28-Sep-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series 3) 31-Dec-2021 $2.49M $2.49M Completed Pre-Clinical Trials
1. Seed Round 23-Oct-2018 Completed Pre-Clinical Trials
To view Cleara Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cleara Biotech Patents

Cleara Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4249912-A1 Phosphorylation of p53 as a prognostic or diagnostic marker for the treatment of senescent cells in a mammal Pending 24-Mar-2022
EP-4500174-A1 Phosphorylation of p53 as a prognostic or diagnostic marker for the treatment of senescent cells in a mammal Pending 24-Mar-2022
US-20250189516-A1 Phosphorylation of p53 as a prognostic or diagnostic marker for the treatment of senescent cells in a mammal Pending 24-Mar-2022
WO-2023180570-A1 Phosphorylation of p53 as a prognostic or diagnostic marker for the treatment of senescent cells in a mammal Inactive 24-Mar-2022
US-20240197824-A1 Anti-senescence compounds and uses for the treatment of cancer Pending 21-Feb-2020 A61K38/1761
To view Cleara Biotech’s complete patent history, request access »

Cleara Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cleara Biotech Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
CoastCap Family Office Minority
Korify Capital Venture Capital Minority
Infinitas Capital Family Office Minority
iSTAR (UAV Solutions) Corporation Minority
Longevitytech.fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Cleara Biotech FAQs

  • When was Cleara Biotech founded?

    Cleara Biotech was founded in 2018.

  • Where is Cleara Biotech headquartered?

    Cleara Biotech is headquartered in Utrecht, Netherlands.

  • What is the size of Cleara Biotech?

    Cleara Biotech has 9 total employees.

  • What industry is Cleara Biotech in?

    Cleara Biotech’s primary industry is Drug Discovery.

  • Is Cleara Biotech a private or public company?

    Cleara Biotech is a Private company.

  • What is Cleara Biotech’s current revenue?

    The current revenue for Cleara Biotech is .

  • How much funding has Cleara Biotech raised over time?

    Cleara Biotech has raised $4.99M.

  • Who are Cleara Biotech’s investors?

    CoastCap, Korify Capital, Infinitas Capital, iSTAR (UAV Solutions), and Longevitytech.fund are 5 of 11 investors who have invested in Cleara Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process